Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2003-05-08 Earnings Release
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec OAI AG english
Earnings Release Classification · 100% confidence The document explicitly states it announces 'Financial results for the first quarter of 2003' and provides detailed financial highlights (Revenues, Operating result, EBITDA, Net loss) and operational updates for that period. This content structure—a summary of financial performance for a period shorter than a year (Q1)—is characteristic of an Interim/Quarterly Report. Although it is presented as a news announcement, the core content is the comprehensive quarterly financial disclosure, making 'Interim / Quarterly Report' (IR) the most appropriate classification over a simple 'Earnings Release' (ER) which usually contains only key highlights, or an 'RPA' which only announces the publication of a report. The length (7469 chars) also supports it being the report content itself rather than a brief announcement. Q1 2003
2003-05-08 English
Quartalsbericht 1/2003
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Erster Quartalsbericht 2003' (First Quarterly Report 2003) for Evotec OAI AG. It contains detailed financial statements, including revenue, operating loss, EBITDA, and earnings per share, along with a comprehensive management discussion and analysis of business performance for the first quarter. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report. Q1 2003
2003-05-08 German
Evotec OAI AG english
Regulatory Filings Classification · 95% confidence The document is a short corporate news announcement dated April 10, 2003, detailing a new collaboration contract signed between Evotec OAI AG and Novartis Pharma AG regarding drug discovery services. It is not a comprehensive financial report (like 10-K or IR), nor is it a transcript, dividend notice, or management change announcement. It is a general business update distributed via a news service (DGAP). Since it is a specific business announcement that doesn't fit the other specialized categories (like M&A, Capital Change, or Director Dealing), the most appropriate classification is the general regulatory/news fallback category, RNS (Regulatory Filings), as it functions as a general market disclosure.
2003-04-10 English
Evotec OAI AG english
Earnings Release Classification · 100% confidence The document text explicitly announces 'Evotec OAI-Financial Results 02: Sustained Growth in Challenging Markets' and provides detailed 'Financial Highlights' for the year ended 31 December 2002, including Revenues, EBITDA, liquidity build-up, and an operational review. This content structure—a summary of annual performance, key metrics, and operational achievements for a full fiscal year—is characteristic of an Annual Report or the primary release associated with it. Since the text provides the core financial summary and operational review, it aligns best with the comprehensive nature of an Annual Report (10-K), although it is presented as a news announcement (likely the Earnings Release or a summary preceding the full 10-K filing). Given the depth of the financial review (including goodwill impairment details and full-year figures), it goes beyond a simple Earnings Release (ER) and serves as the primary disclosure of annual results. However, in the context of SEC filings, this summary announcement is often the precursor or summary of the 10-K. Since the document is a detailed financial results announcement for a full year, and not just a brief highlights release, '10-K' is the most appropriate classification for the underlying comprehensive report being summarized, or 'ER' if strictly classifying the announcement itself. Given the depth (including detailed operational and financial review sections), it strongly suggests the content of the Annual Report. I will classify it as '10-K' as it covers the full year's performance comprehensively. FY 2002
2003-03-25 English
Evotec OAI AG english
Earnings Release Classification · 100% confidence The document is explicitly labeled as an 'Ad-hoc-announcement' and discusses the 'FY 2002' financial performance, including revenues, operating loss, EBITDA, and cash position, along with guidance for 2003. This content—a summary of period results released outside of the standard quarterly/annual filing cycle—is characteristic of an Earnings Release (ER). Although it contains detailed financial figures, its format as a brief, immediate announcement (Ad-hoc) strongly suggests it is the initial release of results rather than the comprehensive Annual Report (10-K) or Interim Report (IR). Given the context of immediate financial disclosure, ER is the most appropriate classification. FY 2002
2003-03-25 English
Annual Report 2002
Annual Report Classification · 100% confidence The document is explicitly titled 'Evotec OAI AG Annual Report 2002'. It contains a comprehensive review of the company's business, management reports, consolidated financial statements (U.S. GAAP), auditor's report, and detailed financial tables for the fiscal year 2002. It is a full-length annual report, not an announcement or summary. FY 2002
2003-03-25 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.